Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Injectable GHK-Cu is not FDA-approved for human use, and site choice should come from a licensed clinician when an injectable medication has actually been prescribed
These manufacturing challenges contribute to FOXO4-DRI's high price relative to smaller research peptides
Compounded medications are custom-prepared by pharmacies, have not undergone FDA clinical trial review, and may have more variability in concentration and quality control
PubMed 16352683) remains the definitive human pharmacology study: CJC-1295 (with DAC) in 57 healthy adults produced 210 GH elevation and 1.53 IGF-1 elevation sustained for 911 days
US$ 22.67
US$ 21.14
US$ 29.02
US$ 29.48
-1775582746855.png&w=3840&q=75)
US$ 29.33
